| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | MMED | United States | $12.16 | $0.00 | Strong Buy | 10 | 2026 |
#2 | AA | United States | $62.83 | $12,831,000,000.00 | Buy | 10 | 2016 |
#3 | NFG | United States | $83.08 | $2,277,541,000.00 | Buy | 4 | 1997 |
#4 | WAY | United States | $21.05 | $1,099,278,000.00 | Strong Buy | 17 | 2023 |
#5 | CDE | United States | $17.64 | $709,598,000.00 | Strong Buy | 5 | 1994 |
#6 | TREE | United States | $38.88 | $1,117,324,000.00 | Strong Buy | 4 | 2008 |
#7 | PTCT | United States | $65.14 | $264,734,000.00 | Buy | 17 | 2006 |
#8 | EYE | United States | $23.49 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#9 | CALX | United States | $43.54 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#10 | WBD | United States | $27.05 | $0.00 | Buy | 21 | 2008 |
#11 | STOK | United States | $33.12 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#12 | IDYA | United States | $28.22 | $218,710,000.00 | Strong Buy | 16 | 2019 |
#13 | W | United States | $64.96 | $0.00 | Buy | 28 | 2014 |
#14 | ERAS | United States | $10.06 | $0.00 | Strong Buy | 12 | 2021 |
#15 | RIVN | United States | $15.12 | $5,387,000,000.00 | Buy | 21 | 2021 |
#16 | PPL | United States | $37.67 | $9,042,000,000.00 | Buy | 13 | 2007 |
#17 | RLAY | United States | $12.79 | $15,355,000.00 | Strong Buy | 10 | 2020 |
#18 | MDT | Ireland | $80.45 | $33,537,000,000.00 | Buy | 21 | 2014 |
#19 | IMCR | United Kingdom | $28.22 | $249,428,000.00 | Buy | 10 | 2016 |
#20 | MRBK | United States | $18.84 | $6,316,000.00 | Strong Buy | 4 | 2018 |
#21 | RYTM | United States | $82.12 | $0.00 | Strong Buy | 14 | 2017 |
#22 | TNGX | United States | $20.97 | $62,384,000.00 | Strong Buy | 10 | 2020 |
#23 | FLS | United States | $71.45 | $0.00 | Strong Buy | 11 | 2006 |
#24 | RRR | United States | $52.65 | $2,011,483,000.00 | Strong Buy | 13 | 2015 |
#25 | OLLI | United States | $85.39 | $2,649,198,000.00 | Strong Buy | 13 | 2015 |
#26 | KTOS | United States | $62.35 | $751,900,000.00 | Strong Buy | 18 | 1999 |
#27 | TCMD | United States | $22.86 | $0.00 | Strong Buy | 4 | 2016 |
#28 | OLMA | United States | $14.41 | $0.00 | Strong Buy | 10 | 2020 |
#29 | ATMU | United States | $52.90 | $1,764,300,000.00 | Buy | 4 | 2023 |
#30 | SNDX | United States | $19.00 | $172,352,000.00 | Strong Buy | 13 | 2014 |
#31 | NMIH | United States | $37.11 | $706,440,000.00 | Buy | 4 | 2013 |
#32 | GGG | United States | $79.01 | $2,236,604,000.00 | Buy | 4 | 1994 |
#33 | CDP | United States | $31.02 | $763,923,000.00 | Buy | 7 | 1996 |
#34 | SCI | United States | $79.75 | $4,309,234,000.00 | Strong Buy | 4 | 1994 |
#35 | HSIC | United States | $73.88 | $13,201,995,000.00 | Buy | 16 | 1996 |
#36 | PNR | United Kingdom | $79.23 | $0.00 | Buy | 16 | 2003 |
#37 | MMSI | United States | $62.13 | $1,515,906,000.00 | Strong Buy | 8 | 1996 |
#38 | GEHC | United States | $61.10 | $20,625,000,000.00 | Buy | 13 | 2022 |
#39 | FE | United States | $46.95 | $15,090,000,000.00 | Buy | 14 | 2005 |
#40 | OPCH | United States | $20.05 | $4,998,202,000.00 | Buy | 7 | 1996 |
#41 | CTSH | United States | $52.33 | $21,108,000,000.00 | Buy | 17 | 1998 |
#42 | TSCO | United States | $33.91 | $15,524,046,000.00 | Buy | 22 | 1996 |
#43 | VALE | Brazil | $16.15 | $0.00 | Buy | 10 | 2007 |
#44 | STNE | Cayman Islands | $11.09 | $0.00 | Buy | 7 | 2018 |
#45 | SNCY | United States | $15.76 | $1,126,769,000.00 | Buy | 7 | 2021 |
#46 | KGC | Canada | $29.57 | $0.00 | Buy | 7 | 1994 |
#47 | AU | United States | $92.50 | $0.00 | Strong Buy | 4 | 2023 |
#48 | BIOA | United States | $16.74 | $0.00 | Strong Buy | 6 | N/A |
#49 | VTVT | United States | $31.80 | $0.00 | Strong Buy | 5 | 2015 |
#50 | QGEN | Netherlands | $34.12 | $0.00 | Buy | 8 | 1998 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (May 3, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.